Skip to content
DraconiticResearch
Search Sources API
197,688 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYJournal of Diabetes

Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials

  1. 1Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China

Related

  1. Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study
    Aika Miya, Michihiro Kaneko, Yuka Ozaki +2
    Diabetology internationalPeer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
  2. Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
    Julio Zúñiga Cisneros, Michael Camilleri, Madhusudan Grover
    Acta gastroenterologica LatinoamericanaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
  3. Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
    S. Leo, I. Dhoparee-Doomah, S. Negi +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
    Wares Jalil
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Beyond medication: rethinking postpartum obesity management in the era of increasing GLP-1 receptor agonist use
    Verena Atud Achick-Muyu
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
BibTeX
@article{yang2026baseline,
  title = {{Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials}},
  author = {Wenjia Yang and Wei Zhao and Xiaoling Cai and Linong Ji},
  journal = {Journal of Diabetes},
  year = {2026},
  month = oct,
  doi = {10.1111/1753-0407.70283},
  url = {https://doi.org/10.1111/1753-0407.70283},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials
AU  - Wenjia Yang
AU  - Wei Zhao
AU  - Xiaoling Cai
AU  - Linong Ji
PY  - 2026
DA  - 2026/10/27
JO  - Journal of Diabetes
DO  - 10.1111/1753-0407.70283
UR  - https://doi.org/10.1111/1753-0407.70283
SN  - 1753-0407
SN  - 1753-0393
ER  -